Politics

Tracking how politics and policy intersect with science and health care

Lactated Ringer's solution
Health

Watchdog group calls for NIH to halt ‘dangerous’ study of sepsis treatment

By Sharon Begley

John McCain
Politics

John McCain has died. For brain cancers like his, ‘research is our only hope’

By Sharon Begley

Pharmalot

Pharmalittle: FDA eyes side-effect lists in drug ads; generic Paxil verdict tossed

By Elizabeth Cooney

Francis Collins on Who is America
Politics

Sacha Baron Cohen tried to prank Francis Collins. He got a science lesson instead

By Lev Facher

Pharmaceutical ads
Pharma

Are long lists of side effects backfiring? FDA wants to know whether drug ads ‘overwarn’ consumers

By Megan Thielking

Charles Grassley & Richard Durbin
Politics

Senate joins push to require pharma to include prices in ads and TV commercials

By Ike Swetlitz

Francis Collins
Politics

NIH is investigating researchers who might have failed to disclose contributions from foreign governments

By Lev Facher

Pharmalot

Pharmalittle: Pharma groups warn Saudis; Medicare struggles over CAR-T

By Elizabeth Cooney

Immunotherapies NIH lab
Politics

Medicare struggles to even set the agenda as it weighs how to pay for CAR-T therapies

By Ike Swetlitz

D.C. Insight IMAGE
Opinions Plus

Public distrust is high, PBMs are the problem, but the future is bright: a survey of biopharma pros

By Elizabeth Cooney

Pharmalot

Pharmalittle: Medicare could save with generic combos; an overlooked CAR-T component

By Elizabeth Cooney

Pharmacy Benefit Managers illustration
Politics

The Trump administration can’t decide whether drug industry middlemen are the enemy — or part of the solution

By Ike Swetlitz

Chimp Rehab
Politics

Hundreds of chimps at the NIH await retirement. This senator wants to help

By Ike Swetlitz

Alex Azar, Betsy DeVos, Ryan Zinke
Politics

FDA kicks off effort to examine importing drugs

By Ike Swetlitz

Epi-Pen for June 22
Politics

FDA approves the first generic version of EpiPen

By Ike Swetlitz

Trump speaking
Politics

Trump wants federal suit against opioid manufacturers

By Associated Press

Laura Dolph
Politics

Tapered to zero: In radical move, Oregon’s Medicaid program weighs cutting off chronic pain patients from opioids

By Lev Facher

Anna Eshoo
Politics

A congresswoman from Silicon Valley wants to lead on health care. New attack ads say she’s ‘in the pocket of Big Pharma’

By Rebecca Robbins

FDA Commissioner Scott Gottlieb
Politics

Gottlieb: FDA will streamline drug safety evaluations

By Ike Swetlitz

Kelvin Droegemeier
Politics

Can this man bring science back to the White House?

By Ike Swetlitz

HHS Secretary Alex Azar
Politics

HHS takes aim at drug companies for an ‘abusive behavior’ in Medicaid

By Ike Swetlitz

Rep. Chris Collins (R-NY)
Politics

‘How are these results even possible?’: Inside Rep. Chris Collins’ painful biotech education

By Damian Garde

President Donald Trump
Politics

Trump’s new tone with drug makers: gratitude

By Ike Swetlitz and Lev Facher

Politics

Drug pricing could be a slam-dunk campaign issue for Democrats — if only they had a plan

By Lev Facher

Seema Verma
Politics

Trump administration moves to give private Medicare plans new leverage over drug costs

By Ike Swetlitz

Politics

Congress requests Sackler deposition that Purdue Pharma is fighting to keep sealed

By Andrew Joseph

A photo of Scott Gottlieb
Politics

FDA will broaden how it evaluates new addiction treatment drugs

By Lev Facher

Immunotherapy scans
Politics

To pay for cutting-edge CAR-T therapies, Medicare plays it safe, for now

By Ike Swetlitz

An illustration of the NIH building surrounded by alcohol bottles and a football field.
Politics

Series of ethical stumbles tests NIH’s reliance on private sector for research funding

By Lev Facher

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy